This site is intended for health professionals only

Editor’s pick

Systagenix unveils SILVERCEL non-adherent silver hydro alginate dressing
Systagenix unveils SILVERCEL non-adherent silver hydro alginate dressing
FDA approves leukaemia drug use
FDA approves leukaemia drug use
Actavis sign a co-developnebt contract with Bioluz
Actavis sign a co-developnebt contract with Bioluz
FDA questioned over drug approvals
FDA questioned over drug approvals
FDA determines VYVANSE was properly granted five-year market exclusivity
FDA determines VYVANSE was properly granted five-year market exclusivity
Merck KGaA revenues increase by 2.7% to €1.9 billion
Merck KGaA revenues increase by 2.7% to €1.9 billion
CHMP issues positive opinion for MICARDIS
CHMP issues positive opinion for MICARDIS
Novartis receives approval in the EU for Exforge HCT
Novartis receives approval in the EU for Exforge HCT
Asthma inhaler design “improved”
Asthma inhaler design “improved”
Drug firms show increased profits
Drug firms show increased profits
Swiss regulatory authority Swissmedic announces results of its analysis
Swiss regulatory authority Swissmedic announces results of its analysis
Novartis excels in product momentum and operational performance
Novartis excels in product momentum and operational performance
1 … 105 106 107 108 109 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x